ROMED: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
ROMED
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€1.6m
2024 · €2.2m-€610,650
Equity
€5.1m
2024 · €5.0m+€18,686
Cash
€1.8m
2024 · €1.6m+€205,306
Balance sheet total
€9.5m
2024 · €8.0m+€1.6m
Largest movements
Assets
- Receivables within one year +€1.0m
up €1.0m (+33.5%), from €3.1m to €4.2m
of which Trade receivables: +€693,252
- Current investments +€500,000
up €500,000 (+33.3%), from €1.5m to €2.0m
- Cash +€205,306
up €205,306 (+12.9%), from €1.6m to €1.8m
mainly Net result for the year (+€1.6m) and Other debts (+€900,000)
- Stocks and contracts -€157,605
down €157,605 (-9.7%), from €1.6m to €1.5m
Equity and liabilities
- Other debts +€900,000
up €900,000 (+128.6%), from €700,000 to €1.6m
- Trade debts +€636,841
up €636,841 (+37.1%), from €1.7m to €2.4m
Income statement
- Gross operating margin -€1.1m
down €1.1m (-32.5%), from €3.3m to €2.2m
- Taxes -€142,461
down €142,461 (-76.5%), from €186,206 to €43,745
- Staff costs +€108,779
up €108,779 (+24.8%), from €438,682 to €547,460
- Financial charges -€55,204
down €55,204 (-58.6%), from €94,214 to €39,010
- Financial income +€32,680
up €32,680 (+41.7%), from €78,361 to €111,041
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€2.2m
Gross operating margin
-€1.1m
Staff costs
-€108,779
Depreciation
-€6,424
Other operating charges
-€14,771
Other operating items
-€1,839
Financial income
+€32,680
Financial charges
+€55,204
Taxes
+€142,461
Deferred taxes and other
+€348,170
Result 2025
€1.6m
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€2.3m
Investment
-€564,191
Financing
-€1.6m
Cash 2024
€1.6m
From operations (derived)
+€2.3m
Net result for the year
+€1.6m
Depreciation
+€22,848
Stocks and contracts
+€157,605
Receivables within one year
-€1.0m
Deferred charges and accrued income
+€75,842
Trade debts
+€636,841
Tax, wage and social debts
+€531
Other debts
+€900,000
Accrued charges and deferred income
-€19,273
Investment (derived)
-€564,191
Investment in fixed assets (net)
-€64,191
Current investments
-€500,000
Financing
-€1.6m
Debts after one year
+€20,250
Current portion of long-term debt
+€2,338
Contributions, distributions and other
-€1.6m
Cash 2025
€1.8m
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €7,963,193 | €9,522,565 | +€1.6m | +19.6% |
| Fixed assets | 21/28 | €18,156 | €59,499 | +€41,342 | +227.7% |
| Intangible fixed assets | 21 | €1,092 | €11,080 | +€9,988 | +914.9% |
| Tangible fixed assets | 22/27 | €17,065 | €48,419 | +€31,354 | +183.7% |
| Furniture and vehicles | 24 | €17,065 | €48,419 | +€31,354 | +183.7% |
| Current assets | 29/58 | €7,945,036 | €9,463,066 | +€1.5m | +19.1% |
| Stocks and contracts in progress | 3 | €1,623,121 | €1,465,516 | -€157,605 | -9.7% |
| Stocks | 30/36 | €1,623,121 | €1,465,516 | -€157,605 | -9.7% |
| Amounts receivable within one year | 40/41 | €3,125,968 | €4,172,139 | +€1.0m | +33.5% |
| Trade receivables | 40 | €1,871,173 | €2,564,425 | +€693,252 | +37.0% |
| Other amounts receivable | 41 | €1,254,795 | €1,607,714 | +€352,919 | +28.1% |
| Current investments | 50/53 | €1,500,000 | €2,000,000 | +€500,000 | +33.3% |
| Cash at bank and in hand | 54/58 | €1,593,871 | €1,799,177 | +€205,306 | +12.9% |
| Deferred charges and accrued income | 490/1 | €102,076 | €26,234 | -€75,842 | -74.3% |
| Total equity and liabilities | 10/49 | €7,963,193 | €9,522,565 | +€1.6m | +19.6% |
| Equity | 10/15 | €5,045,416 | €5,064,102 | +€18,686 | +0.4% |
| Contributions | 10/11 | €131,000 | €131,000 | = | 0.0% |
| Capital | 10 | €131,000 | €131,000 | = | 0.0% |
| Issued capital | 100 | €131,000 | €131,000 | = | 0.0% |
| Reserves | 13 | €1,329,512 | €1,329,512 | = | 0.0% |
| Non-distributable reserves | 130/1 | €13,100 | €13,100 | = | 0.0% |
| Legal reserve | 130 | €13,100 | €13,100 | = | 0.0% |
| Tax-exempt reserves | 132 | €1,255,009 | €1,255,009 | = | 0.0% |
| Distributable reserves | 133 | €61,402 | €61,402 | = | 0.0% |
| Profit (loss) carried forward | 14 | €3,584,904 | €3,603,590 | +€18,686 | +0.5% |
| Provisions and deferred taxes | 16 | €348,170 | €348,170 | = | 0.0% |
| Deferred taxes | 168 | €348,170 | €348,170 | = | 0.0% |
| Amounts payable | 17/49 | €2,569,607 | €4,110,293 | +€1.5m | +60.0% |
| Amounts payable after more than one year | 17 | - | €20,250 | +€20,250 | |
| Financial debts | 170/4 | - | €20,250 | +€20,250 | |
| Amounts payable within one year | 42/48 | €2,550,334 | €4,090,043 | +€1.5m | +60.4% |
| Current portion of amounts payable after more than one year | 42 | €6,662 | €9,000 | +€2,338 | +35.1% |
| Financial debts | 43 | €10,000 | €10,000 | = | 0.0% |
| Credit institutions | 430/8 | €10,000 | €10,000 | = | 0.0% |
| Trade debts | 44 | €1,715,328 | €2,352,169 | +€636,841 | +37.1% |
| Suppliers | 440/4 | €1,715,328 | €2,352,169 | +€636,841 | +37.1% |
| Taxes, remuneration and social security | 45 | €118,344 | €118,875 | +€531 | +0.4% |
| Taxes | 450/3 | €82,909 | €82,909 | = | 0.0% |
| Remuneration and social security | 454/9 | €35,435 | €35,965 | +€531 | +1.5% |
| Other amounts payable | 47/48 | €700,000 | €1,600,000 | +€900,000 | +128.6% |
| Accrued charges and deferred income | 492/3 | €19,273 | - | -€19,273 | |
| Non-recurring operating income | 76A | €132,306 | €31,317 | -€100,989 | -76.3% |
| Remuneration, social security and pensions | 62 | €438,682 | €547,460 | +€108,779 | +24.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €16,424 | €22,848 | +€6,424 | +39.1% |
| Other operating charges | 640/8 | €23,325 | €38,096 | +€14,771 | +63.3% |
| Non-recurring operating charges | 66A | - | €1,839 | +€1,839 | |
| Gross operating margin | 9900 | €3,257,996 | €2,200,643 | -€1.1m | -32.5% |
| Operating profit (loss) | 9901 | €2,779,565 | €1,590,400 | -€1.2m | -42.8% |
| Financial income | 75/76B | €78,361 | €111,041 | +€32,680 | +41.7% |
| Recurring financial income | 75 | €78,361 | €111,041 | +€32,680 | +41.7% |
| Financial charges | 65/66B | €94,214 | €39,010 | -€55,204 | -58.6% |
| Recurring financial charges | 65 | €94,214 | €39,010 | -€55,204 | -58.6% |
| Profit (loss) for the period before taxes | 9903 | €2,763,712 | €1,662,431 | -€1.1m | -39.8% |
| Transfer to deferred taxes | 680 | €348,170 | - | -€348,170 | |
| Income taxes | 67/77 | €186,206 | €43,745 | -€142,461 | -76.5% |
| Profit (loss) for the period | 9904 | €2,229,336 | €1,618,686 | -€610,650 | -27.4% |
| Transfer to tax-exempt reserves | 689 | €1,044,509 | - | -€1.0m | |
| Profit (loss) for the period to be appropriated | 9905 | €1,184,827 | €1,618,686 | +€433,859 | +36.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.